AptarGroup Inc
ATR: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| r>j | LOCK|!C^%s | LOCK|@^bNph |
Aptar Earnings: Underlying Business Remains Solid Despite Lower Margins
Aptar's fourth-quarter revenue grew 14% year on year on a reported basis and 5% on a core basis, with prescription medicines rising 1% despite inventory destocking in emergency medicines. Adjusted EBITDA margin declined 320 basis points to 19.8%. Shares closed up 8% on Feb. 6.
